InvestorsHub Logo
icon url

shadolane

10/19/19 1:18 PM

#220180 RE: IgnoranceIsBliss #220178

The question I have is what caution is necessary?

Seem to me that would be artificial.

icon url

rosemountbomber

10/19/19 1:24 PM

#220181 RE: IgnoranceIsBliss #220178

That damn revolving door swings back and forth between BP and FDA.
icon url

couldbebetter

10/19/19 1:54 PM

#220187 RE: IgnoranceIsBliss #220178

HCTB, Why would BP want the FDA to grant a narrow label..."IF" BP has
the intent to acquire AMRN, then wouldn't BP want to have the FDA grant as broad of a label as possible now...so when they own AMRN they will be able to benefit in the future from the broad label being granted?
icon url

jessellivermore

10/19/19 2:23 PM

#220194 RE: IgnoranceIsBliss #220178

JB...

I appreciate your point of view. and I don't rule it out completely, but I don't think it is going to go down that way...(we will find out in about a month)..

We are all a little paranoid after 2013..I do not (as posted earlier) think that an extended (wide) label is necessary for this drug..Doctors are not all stupid and most of them are going to believe the R-I results..There will be the skeptics...but IMO they will be a small minority...I don't think there is much to be cautious about. Have you listened to all these drugs be advertised on TV...

":>) JL
icon url

ziploc_1

10/19/19 2:39 PM

#220197 RE: IgnoranceIsBliss #220178

BP...I hope this theory does not apply to any of the panelists or the FDA team, who will be deciding on the Vascepa label on November 14.

Many thousands, perhaps even millions, of lives are at stake here.